To study the mechanism of L protein-mediated, intracellular (pre-Golgi) retention of hepatitis B virus (HBV) surface proteins, a collection of HBV preS-S open reading frame variants bearing wild-type or modified preS extensions was expressed in human cells. When the secretion phenotype of the corresponding proteins was analysed, all surface proteins with rearranged preS domains were found to be at least partially retained. This held true, in particular, for two variant proteins lacking preS1 amino acids 1 to 19 (ayw), the preS1 myristylated N terminus and a putative retention domain, and for another variant lacking the entire preS1 domain plus the N-terminal portion (amino acids 1 to 12) of the preS2 domain. All the retained variants underwent intracellular dimerization/oligomerization via disulphide bonds to a degree comparable to that observed in well exported natural proteins. Our results show that retention can take place in the absence of L Nterminal sequences and does not imply inhibition of covalent oligomerization.
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Compelling evidence indicates that proteins routed to the secretory pathway are transported towards the cell surface by default, whereas retention in a specific compartment usually requires special signals (Rothman & Orci, 1992) . A number of rough endoplasmic reticulum (ER) soluble resident polypeptides have been found to share a C-terminal sequence (KDEL for mammalian cells, in the one-letter amino acid code). This sequence is thought to assure steady-state ER residence by interaction with a KDEL receptor which shuttles between the ER and an intermediate compartment (Pelham, 1989) . The residence in the ER or Golgi apparatus of certain membrane proteins is specified by cytoplasmic anchor sequences, and/or by hydrophobic transmembrane domains (Rose & Doms, 1988 ; Pelham, 1989; Hurtley, 1992) . Among viral glycoproteins, thoroughly studied models of retention are provided by surface proteins of viruses that utilize the exocytic pathway for virion release, e.g. rotavirus VP7 protein and coronavirus E1 protein (Stephens & Compans, 1988) . In these cases, the site of retention appears to dictate where the glycoprotein interacts with the other virion components for assembly and maturation.
A recently characterized example of pre-Golgiretained protein is the L protein of hepatitis B virus (HBV), the hepadnavirus causing hepatitis B in humans (Blum et al., 1989; . L is the largest of the three HBV surface glycoproteins, which are encoded by a single HBV gene [the open reading frame (ORF) preS-S; Fig. l(a) ] and share a common Cterminal domain (the S domain) (Heermann et al., 1984) . The S (or major, as it is the most abundant) protein coincides with the S domain; the M protein bears a 55 amino acid extension (the preS2 region) at the N terminus of the S domain; the L protein bears a 163 to 174 amino acid N-terminal extension (the preS 1 + 2 region), fusing a further 108 to 119 amino acids (the preS1 region) to the preS2 N-terminal methionine. The N terminus of L is myristylated (Persing et al., 1987) . S, M and L not only form HBV virion peplomers, but, as a peculiarity of hepadnaviridae biology, are also secreted as noninfectious 22 nm spherical or tubular particles devoid of a nucleocapsid core. Such particles, which incorporate cell lipids in a non-bilayer arrangement, constitute the HBV surface antigen (HBsAg) (Heermann et al., 1984; Ganem, 1991) . According to an accepted view, HBsAg secretion is a multistep event in which HBV surface polypeptides fold across the ER bilayer in a polytopic orientation and oligomerize excluding host proteins. They subsequently undergo budding, and travel as soluble lipoprotein particles inside transport vesicles (Eble et al., 1986 (Eble et al., , 1987 Patzer et al., 1986; Simon et al., 1988; Bruss & Ganem, 1991a; Huovila et al., 1992) . Whereas in HBV virions and HBsAg tubules the L protein is well represented (up to 20 %), it is much less abundant in HBsAg spherical particles. Studies of expression of a cloned preS-S gene demonstrated that S is the only form required for HBsAg particle secretion, and that most eukaryotic cells can cope with the entire process (Ganem, 1991 Blum et al., 1989) . ORF preS-S is a "nested' gene, exploiting three in-frame AUGs to encode three corresponding carboxy coterminal proteins. L protein, the largest envelope form, is translated starting at AUGI on a 2.4 kb mRNA template, whose transcription is driven by promoter SPI. M protein, the intermediate form, and S protein, the smallest, are translated from AUG2 and AUG3, respectively, on the 2.1 kb mRNA transcribed from promoter SPH. Whereas AUG1, surrounded by a favourable sequence context, is able to capture the majority of translational starts on 2.4 kb mRNA, AUG2, lying in a 'weak' context, allows a leaky scanning approx. 50% in favour of AUG3. Moreover, a fraction of 2.1 kb mRNAs initiate downstream of AUG2, thus expressing only the S protein. Tall angled arrow: strong-context AUG; short angled arrow, weak-context AUG; pA, HBV transcriptional termination/poly(A) signal; (A)n , HBV transcripts poly(A) tail. NLO, N-linked oligosaccharide; myr, myristylated molecule. (b) ORF preS-S variants utilized in this study, and a summary of data on modification and export of the corresponding proteins. The plasmids pRPAUG3, pRPAUG2.3, pRPAUG1.2.3ayw, pRPAUG1.2.3adw2, pRPAUG2. 2. 3, pRPAUG1.3ayw and pRPAUG1.3adw2 have been described (Gallina et al., 1992) . The remaining plasmids were constructed with standard recombinant DNA techniques (Sambrook et al., 1989) , as follows. Plasmid pRPpreSIA insert was created by ligating the adapter 5' P-GATCTGCCGCCACCATG 5' including an in-phase AUG in a strong translational context, to the BamHI end of the HBV DNA ACGGCGGTGGTACCTAG-P (ayw) fragment BamH12906-BglI12896. The same adapter was ligated to the BarnHI end of the fragment BamHI 30~BglI12896 (adw2) to create the pRPpreS2A insert. Construct pRPMstAUG insert bears the AUG adapter ~' v GmCTGCCGCCACCmGGCC~GG ligated to
HBV DNA (adw2) fragment EcoRI O~BglII 2986. Abbreviations: myr. site, preS 1 myristylation site; glyc. sites, N-linked glycosylation sites [preS 1, ayw: Asn(4);; preSt, adw2: Asn(15); preS2: Asn(4) ; S: Asn (146)]. p/m +, present and efficiently modified; p/m +_, present and inefficiently modified; p/nu: present but unused. NT, not tested. ( §) The preS2 glycosylation site was present twice in the chimeric preS extension of pRPAUG2.2.3 full-length product. Secretion ratios (percent) indicated in the RIP column were calculated from densitometric profiles of the 3 h pulse/18 h chase autoradiographs, and refer to total (intracellular plus secreted) HBV envelope protein synthesized by each transfectant; reported values are the average of duplicate experiments. In the EIA column, intra-and extracellular HBsAg was measured in 293 cell transfectants 72 h after transfection, using a commercial enzyme immunoassay (Auszyme, Abbott).
(c) The episomal vector used to express preS-S variants (Manservigi et al., 1990) . Insert expression was directed by RSV LTR. Vector episomal amplification in human cells was assured by the replication origin of BK virus (or/) and by the expression of the BK virus gene coding for T/t antigen (T/t Ag), driven by promoter Pw inhibited when the L protein is co-expressed to high levels. S and L polypeptides are then jointly retained within a pre-Golgi compartment (Cheng et al., 1986; Chisari et al., 1986; Persing et al., 1986; Standring et al., 1986; Ou & Rutter, 1987; McLachlan et al., 1987) . It has been speculated that L-mediated retention might reflect a role for L in virion assembly (Gabem, 1991) , in keeping with the finding that L, like S, is necessary for virogenesis (Bruss & Ganem, 1991b) ; however, L overexpression was found to inhibit virion release as well (Bruss & Ganem, 1991b) . The interest of studying L retention is strengthened by the involvment of HBsAg intracellular accumulation in chronic hepatitis B as a factor promoting cell injury and possibly initiating a degenerative sequela to hepatocellular carcinoma (HCC). In a transgenic mouse model expressing L protein in hepatocytes, high producer lineages regularly develop HCC (Chisari et at., 1989) . The search for L retention signals has focused on the preS 1 + preS2 domain distinctive ofL. A study, analysing a collection of preS1 deletion derivatives of L produced in COS-7 cells (Kuroki et al., 1989) , has implicated amino acids 6 to 19 at the N terminus of L (subtype adw) as a retention sequence, with the N-terminal myristic acid constituting an additional and separable retention factor. Another work demonstrated that, in HepG2 cells, N-terminal myristylation can block secretion of HBsAg even in the absence of any preS sequence (Prange et aI., 1991) . In a previous report, we described a chimeric L protein mutant lacking the preS1 N-terminal sequence and still being substantially retained (Gallina et al., 1992) . Here, we re-examine this issue, analysing a wider series of mutations in the preS region for their effects on envelope protein secretion.
Initially we considered a series of nine ORF preS-S derivatives (Fig. 1 b) , placed under the transcriptional control of the Rous sarcoma virus (RSV) long terminal repeat (LTR), into the cloning site of vector pRPRSV (Manservigi et al., 1990; Gallina et al., 1992;  Fig. 1 c) . They included a group bearing rearrangements in the preS domain, potentially informative about the preS sequence/retention relationship: plasmids pRPpreS1A, pRPAUG2. 2. 3, pRPAUG1.3ayw, pRPAUGI1.3adw2 and pRPpreS2A. Mutants AUG2.2.3, AUG1.3ayw and AUG1.3adw2 have been described previously (Gallina et al., 1992) . Plasmids pRPpreS1A and pRPpreS2A express Y-terminally deleted versions of ORF preS-S. Mutant preS1A fuses a strong context AUG (Kozak, 1989) to preS1 codon 19 (ayw), thus eliminating codons 1 to 18 of the ORF. Mutant preS2A fuses a strong context AUG to preS2 codon 13, deleting the entire preS 1-coding region plus preS2 codons 1 to 12. In addition, the series included controls devised to express the well secreted S or M proteins (pRPAUG3 and pRPAUG2.3, respectively) or the retained L protein of either ayw or adw2 subtype (constructs pRPAUG-1.2.3ayw and pRPAUG1.2.3adw2). The reason for comparing ayw and adw2 subtype variants in construct pairs AUG1.3 and AUG1.2.3 was the presence in adw strains of an additional 11 amino acid stretch at the N terminus. This includes the first six residues of the possible retention signal identified by Kuroki et al. (1989) , in particular a basic motif [Lys(7)-Pro(8)-Arg(9)-Lys(10)] recalling C-terminal cytoplasmic anchor sequences.
Variant constructs were expressed transiently in the human cell line 293 (Graham et al., 1977) . Cells, cultured in Dulbecco's modification of Eagle's medium (DMEM) with 10% fetal calf serum (FCS), were plated at 1 x 106 per 9 cm 2 well in multiwell plates and transfected with 5 lag plasmid DNA, using the calcium phosphate coprecipitation technique (Gorman, 1985) . Two days posttransfection, cells were labelled with a 3 h [35S]methionine pulse (140 gCi; Amersham) in methionine-free DMEM, and dissolved in lysis buffer (50 mM-Tris-HC1 pH 8, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate, 20 mM-disodium-EDTA, 1 mM-PMSF). The soluble extract was subjected to immunoprecipitation with sheep anti-HBsAg-Sepharose, followed by reducing SDS-PAGE and fluorography, as described (Gallina et al., 1992) .
Autoradiographs (Fig. 2a) showed the polypeptides expected as the full-length translation products of each preS-S insert. Expectedly, constructs expressing preS extensions (that is, all variants except the S-encoding pRPAUG3) also produced various amounts of wild-type (wt) M and S from internal AUG2 and AUG3, owing to an imperfect dominance of the 5'-most AUG (and, when present, to a residual activity of HBV promoter SPII; Fig. l a, b) . The translational 'leaky scanning' effect (Kozak, 1989) was prominent only for constructs pRPAUG2.3 and pRPAUG2.2.3, whose preS-S inserts bear as the Y-proximal start codon AUG2, a weak initiator favouring translational starts downstream (Gallina et al., 1992) .
HBV envelope polypeptides produced in transfected cells were partly modified with N-linked oligosaccharides within their preS extensions, as shown schematically in Fig. 1 (b) ; all were partly modified at Asn(146) within the S domain. Furthermore, by replacing the [35S]methionine pulse with overnight labelling with [3H]myristic acid (500 ~tCi/well), we verified by immunoprecipitation that the proteins including the preS1 N terminus (the main product of pRPAUG1.2.3ayw, pRPAUG1.2.3adw2, pRPAUG1.3ayw and pRPAUG1.3adw2) were efficiently myristylated at glycine 2 (Fig. 2a, lanes MYR, and  Fig. 1 b) .
The transport properties of the preS-S variants were 1:1 proportion (approx.) generated by pRPAUG2.3, was as expected quite efficiently secreted (approx. 55 % secretion), with only a moderate reduction relative to the S protein alone (approx. 80 % of S secretion). For all the other preS-S variants, a much stronger depression of surface protein secretion was demonstrated. The mutant preS-S products of pRPpreS1A, pRPAUG1.3ayw and pRPAUG1.3adw2, as well as both L subtype variants (pRPAUG1.2.3ayw and pRPAUG1.2.3adw2), were strongly retained. Only longer (1 week) exposures of gels allowed clear visualization of trace amounts of them in the secreted fraction (roughly estimated as much less than 10 % in Fig. 1 b) .
The products of pRPAUG2.2.3 and pRPpreS2A were also weakly secreted (approx. 14% secreted protein, approx. 20% of S secretion; and approx. 23 % secreted protein, approx. 30 % of S secretion, respectively).
In another series of experiments, a different experimental format was adopted. At 72 h post-transfection, culture media were collected and clarified, and cells were harvested and lysed with a buffer including a non-ionic detergent (50 mM-Tris-HC1 pH 8, 150 mM-NaCI, 0.2% Triton X-100, 5mM-disodium-EDTA, 1 mM-PMSF). Nuclei were eliminated by centrifugation, and cell extracts were brought to the volume of culture supernatants with fresh culture medium. Intra-and extracellular HBsAg was then measured with a commercial immunoassay (Auszyme, Abbott). Secretion ratios calculated in this way [ Fig. 1 (b) , secretion, enzyme immunoassay (EIA) column] are a large overestimate of secretion, because they do not take into account the accumulation of secreted HBsAg nor the intracellular breakdown of retained proteins, and because the assay is calibrated for particulate, secreted HBsAg. However, this method allowed a better appreciation of differences in the secretion of strongly retained variants. L protein proved slightly more inhibitory than rearranged variants in these experiments. Based on these results, proteins could be ordered with respect to their degree of retention: Layw Ladw2 > preS1A > AUG1.3ayw ~ AUG1.3adw2. The data reported above show that not only the preS-S variants including preS1 N-terminal sequences (pRPAUG1.2.3ayw, pRPAUG1.2.3adw2, pRPAUG-1.3ayw and pRPAUG1.3adw2) were retained, but also a mutant lacking preS1 amino acids 1 to 19 (ayw) (pRPpreS l A). Moreover, significant secretion inhibition was observed for a protein (pRPAUG2. 2. 3) fusing preS2 amino acids 1 to 12 to preS1 amino acid 26 (adw2), thus bearing a serial duplication of the preS2 N terminus in place of the preS1 natural N terminus, and for a protein eliminating all preS1 amino acids plus the first 12 preS2 amino acids (pRPpreS2A). On the other hand, the wt preS 1 + 2 domain was apparently more inhibitory of secretion than all preS mutants.
All surface protein variants that were strongly retained were over-expressed with respect to S. M, on the other hand, was expressed with S in a 1 : 1 ratio and was only minimally retained relative to the S control. To investigate a possible inhibitory effect of larger relative amounts of M on HBsAg secretion, a preS2-S variant over-expressing M over S was constructed. A mutated version of pRPAUG2.3 was generated, plasmid pRPMstAUG, in which a strong context AUG replaced the natural AUG2; as a consequence of the need for a guanine at the first position after the AUG, wt preS2 codon CAG-2 (Gln) was mutated to GCC-2 (Ala) (see legend to Fig. 1 b) . As expected, pRPMstAUG transfectants synthesized a large excess of the M point mutant (M*) with respect to S. However, when tested for secretion, M* showed secretion values superimposable upon those observed with the 1 : 1 M/S ratio ( Fig. 2b and Fig. l b) . Thus, even when overexpressed, M is not significantly retained. Similar evidence could be found in a report by Cheng & Moss (1987) exploiting the vaccinia virus expression system in CV-1 cells.
A major difficulty in interpreting the above results was to ascertain whether retention of proteins with rearranged preS domains was due to a mechanism homologous to that trapping wt L, and not to unrelated ER quality control processes, which have been known to block the transport of misfolded glycoproteins (Rose & Doms, 1988; Klausner & Sitia, 1990) . The following experiments demonstrated a strong homogeneity in the early transport steps of all the variants considered, and supplied circumstantial evidence against a major role of quality control.
(i) The sugars of intracellular envelope variants produced in pulse-chase experiments were found to be totally sensitive to digestion by endoglycosidase H, which is effective only on high-mannose oligosaccharides (data not shown). The absence of Golgi-trimmed sugars on all of the intracellular envelope variants considered indicates that the passage from ER to Golgi apparatus was the rate-limiting step for secreted proteins, and that a pre-Golgi compartment was the site of accumulation of all retained variants, in agreement with previous reports (Patzer et al., 1986; Kuroki et al., 1989) .
(ii) Plasmids encoding the strongly retained variants were cotransfected with pRPAUG3, adjusting plasmid amounts to progressively lower the preS-S to S synthesis ratio. Secretion, as visualized by immunoprecipitation, expectedly increased with the relative proportion of S, and preS-S polypeptides were included in secreted HBsAg (data not shown).
(iii) When the degree of covalent oligomerization of intracellular envelope proteins, via disulphide bond formation, was studied by comparing their electrophoretic mobility under reducing or non-reducing con-ditions, all envelope variants were found to be prevailingly in a dimeric form, with a minor fraction migrating as a tetramer, and some amount of higher order multimers failing to enter the resolving gel matrix. A similar distribution was observed in S and M+S secreted particles (data not shown). Covalent oligomerization has been previously reported for polypeptides in natural circulating HBsAg (Peterson, 1987) and for intracellular S polypeptide in transfected mammalian cells (Huovila et al., 1992) . Importantly, a recent report suggested that both higher order oligomerization and budding of HBsAg take place in a post-ER, pre-Golgi compartment (Huovila et al., 1992) . Our findings could therefore indicate that wt L, as well as the retained preS mutants, can exit the ER and reach an intermediate compartment.
Taken together, these observations suggest that, similar to wt L, envelope variants carrying mutated preS extensions were retained in a pre-Golgi compartment along the secretory route, could oligomerize forming disulphide bonds to a degree comparable to that of exported S and M proteins, and secretion could be restored by S polypeptide co-expressed in excess. Thus, the presence of a rearranged preS extension does not absolutely prevent the preS-S polypeptide from undergoing budding and secretion, nor does it seemingly induce misfolding of the constant S domain. The last point is in concordance with the view of the preS1 +2 region as an exoplasmic domain (Eble et al., 1990; Kuroki et al., 1990) which folds independently of the transmembrane S portion (Delos et al., 1991 ; Howard et al., 1991) .
In summary, in our expression system, retention of HBV surface proteins did not show a strict correlation with the presence of the N-terminal portion of preS1, where the myristic acid adduct and a putative endoplasmic retention signal (ERS; Kuroki et al., 1989) are located. The simplest interpretation of our results is that preS1 sequences downstream from the myristylated N terminus and from the possible ERS are important for the retention function of the L protein, and that this function could involve the preS2 domain as well.
At least two models seem compatible with these conclusions. In one model, an extension of that proposed by Kuroki et al. (1989) , who emphasized the function of N-terminal retention elements, distinct independent retention signals would be distributed along the preS 1 + 2 sequence, with at least one mapping downstream from amino acid 19 (ayw). One such signal, or part of a signal, might map in particular within the preS2 region, and be exposed in the context of the complete preSl + 2 domain of L, and imperfectly in deletion variant preS2A, while being masked by the conformation of the wt M (and M*) preS2 region. In an alternative model, the function of preS amino acids would be indirect: whereas the folding of the preS2 domain in the M protein enables the completion of the HBsAg secretion process, a complete preSl+2 domain (and to various degrees deletion derivatives of preS regions) would induce the unmasking of retention signals hidden in the S domain. The recent demonstration that S deletion variants lacking a Cterminal hydrophobic stretch or internal sequences (Prange et at., 1992) are retained in a pre-Golgi compartment, although they can oligomerize with co-expressed wt S, might support the idea that cryptic retention sequences are present inside the S domain.
Our findings are substantially in agreement with those from Streeck and coworkers (Prange et at., 1991) and Yu (1991) who showed that L mutants with lesions similar to that in preS1A were very sparingly secreted by HepG2 and COS-7 cells, respectively, although their expression system induced the constitutive synthesis of approximately equimolar amounts of S protein. If one accepts the hypothesis that L retention is involved in virogenesis, then our data are also in agreement with the previous observation that the myristic acid moiety of L and preS1 amino acids 1 to 26 (adw) is essential for virus infectivity but not for virogenesis (Bruss & Ganem, 1991b; MacRae et al., 1991) .
